Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Author Correction: β-catenin drives resistance to PI3K and AKT inhibitors and promotes colon cancer metastasis by disrupting FOXO3a function

  • By

  • Stephan P. Tenbaum

  • Paloma Ordóñez-Morán

  • Isabel Puig

  • Irene Chicote

  • Oriol Arqués

  • Stefania Landolfi

  • Yolanda Fernández

  • José Raúl Herance

  • Juan D. Gispert

  • Leire Mendizabal

  • Susana Aguilar

  • Santiago Ramón y. Cajal

  • Simó Schwartz

  • Ana Vivancos

  • Eloy Espín

  • Santiago Rojas

  • José Baselga

  • Josep Tabernero

  • Alberto Muñoz

  • Héctor G. Palmer

  • October 22, 2026

Share

Objective:

Correct an image error in Fig. 6b of the originally published report.

Approach:
  • Correction: The “T49, Xenograft” panel in Fig. 6b had duplicated an image from Fig. 1b. The corrected panel contains a different representative confocal image corresponding to the staining described.
Key Findings:
  • The correction amends the identified image duplication in the original article.
Interpretation:

The notice addresses the figure error; it does not report other changes to the study.

Conclusion:

The report appeared online on 20 May 2012 and is associated with DOI 10.1038/nm.2772.

Sources:

Original Source(s)

Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

  • by Stephan P. Tenbaum, Paloma Ordóñez-Morán, Isabel Puig, Irene Chicote, Oriol Arqués, Stefania Landolfi, Yolanda Fernández, José Raúl Herance, Juan D. Gispert, Leire Mendizabal, Susana Aguilar, Santiago Ramón y. Cajal, Simó Schwartz, Ana Vivancos, Eloy Espín, Santiago Rojas, José Baselga, Josep Tabernero, Alberto Muñoz, Héctor G. Palmer

  • October 22, 2026

Related Content

Stereotactic body radiation therapy in elderly patients with spinal metastases

Musings from The Power List: Piers Ingram

Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and how artificial intelligence can shape the next generation of medicines

  • October 20, 2026

  • 5 min
CAR NK Cells Target Cancer and Autoimmunity

mRNA nanoparticles reprogram NK cells in vivo, inducing tumor remissions and reducing autoimmune liver damage in mice.

  • October 21, 2026

  • 2 min